This clinical study is evaluating a potential new treatment for Chronic Obstructive Pulmonary Disease (COPD), a common lung condition that causes restricted airflow and breathing difficulties. Current treatments, such as inhalers and steroids, can relieve symptoms but do not stop the disease from progressing.
Genetic studies have linked a specific gene to worsening lung function and chronic lung diseases. This study is testing an inhaled drug that targets this gene, with the aim of reducing lung inflammation.
The purpose of this study is to evaluate the safety and tolerability of multiple doses of the study drug in healthy participants who smoke.
For this part of the study, we are looking for healthy participants aged 18–55 who currently smoke at least 10 cigarettes per day and have been regular smokers for at least 12 months.
Be 18 to 55 years old
Both males or females
